# Clinical-immunological Features of Anti-NMDAR Encephalitis

> **NCT05738668** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 400 (estimated)

## Conditions studied

- Anti NMDA Receptor Encephalitis

## Interventions

- **OTHER:** Description of clinical characteristic

## Key facts

- **NCT ID:** NCT05738668
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2025-02-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05738668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05738668, "Clinical-immunological Features of Anti-NMDAR Encephalitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05738668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*